Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $725,741 - $916,145
4,100 Added 215.79%
6,000 $1.32 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $2.68 Million - $3 Million
-14,800 Reduced 88.62%
1,900 $345,000
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $974,948 - $1.15 Million
-5,200 Reduced 23.74%
16,700 $3.37 Million
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $4.1 Million - $4.78 Million
-19,800 Reduced 47.48%
21,900 $4.71 Million
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $2.15 Million - $2.55 Million
8,400 Added 25.23%
41,700 $11.3 Million
Q2 2020

Aug 12, 2020

BUY
$225.48 - $295.8 $2.44 Million - $3.19 Million
10,800 Added 48.0%
33,300 $9.67 Million
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $5.01 Million - $6.22 Million
-25,100 Reduced 52.73%
22,500 $5.35 Million
Q4 2019

Feb 12, 2020

BUY
$166.71 - $223.91 $116,697 - $156,737
700 Added 1.49%
47,600 $10.4 Million
Q3 2019

Nov 12, 2019

BUY
$166.23 - $187.09 $1.26 Million - $1.42 Million
7,600 Added 19.34%
46,900 $7.95 Million
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $1.43 Million - $1.66 Million
8,700 Added 28.43%
39,300 $7.21 Million
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $5.01 Million - $5.96 Million
30,600 New
30,600 $5.63 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.